Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study Local ablative therapy, such as radiotherapy or surgery, plays a key role in treatment of ...
Abemaciclib Plus Fulvestrant in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Final Overall Survival Results From MONARCH 2 ...
Advanced high-powered precision radiotherapy has been called a "game changer" for patients in the south west by charity ...
Stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) have revolutionized precision oncology by delivering high‐dose, conformal radiation with submillimeter accuracy.
What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...
MIAMI, FL – February 15, 2024 – A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive ...
Please provide your email address to receive an email when new articles are posted on . Stereotactic ablative body radiotherapy provided 100% disease control for 3 years. Only one patient required ...
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
Stereotactic ablative radiotherapy led to promising disease control in patients with metastatic gynecologic cancers, research showed. Stereotactic ablative radiotherapy (SABR) can be a promising and ...
A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found that high-precision radiation therapy is safe for use in patients with cancer that has spread to ...
A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results